Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | GLS | O94925 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6786134 | 0.98 | TDP1 (0.64) | TDP1L3MBTL1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL30632351 | 0.98 | TDP1 (0.64) | TDP1L3MBTL1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL9536378 | 0.98 | TDP1 (0.64) | TDP1L3MBTL1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL31622484 | 0.94 | MAPT (0.62) | TDP1L3MBTL1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL5312972 | 0.94 | MAPT (0.62) | TDP1L3MBTL1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL6790333 | 0.89 | TDP1 (0.71) | TDP1L3MBTL1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL8862878 | 0.87 | TDP1 (0.75) | TDP1L3MBTL1 | |
| SCHEMBL2604742 | 0.87 | TDP1 (0.75) | TDP1L3MBTL1 | |
| SCHEMBL8862728 | 0.87 | TDP1 (0.75) | TDP1L3MBTL1 | |
| SCHEMBL6777483 | 0.87 | TDP1 (0.75) | TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1660560-B1 | PHASE TRANSFER CATALYZED METHOD FOR PREPARATION OF POLYETEHRIMIDES | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2016-03-23 | — | — | EP | claimed |
| US-7714095-B2 | Phase transfer catalyzed method for preparation of polyetherimides | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-05-11 | — | — | US | claimed |
| JP-2009521548-A | — | — | 2009-06-04 | — | — | JP | claimed |
| CN-101374908-A | Foamed and foamable high glass transition temperature polymers | GEN ELECTRIC (US) | 2009-02-25 | — | — | CN | claimed |
| CN-101370873-A | Annular or tubular shaped articles of novel polymer blends | GEN ELECTRIC (US) | 2009-02-18 | — | — | CN | claimed |
| CN-101370872-A | Food service articles of manufacture comprising high temperature polymers | GEN ELECTRIC (US) | 2009-02-18 | — | — | CN | claimed |
| CN-101351506-A | High glass transition temperature thermoplastic articles | GEN ELECTRIC (US) | 2009-01-21 | — | — | CN | claimed |
| EP-1989246-A2 | PHASE TRANSFER CATALYZED METHOD FOR PREPARATION OF POLYETHERIMIDES | Sabic Innovative Plastics IP B.V. (NL) | 2008-11-12 | — | — | EP | claimed |
| EP-1966320-A2 | HIGH GLASS TRANSITION TEMPERATURE THERMOPLASTIC ARTICLES | General Electric Company (US) | 2008-09-10 | — | — | EP | claimed |
| EP-1963433-A2 | ANNULAR OR TUBULAR SHAPED ARTICLES OF NOVEL POLYMER BLENDS | General Electric Company (US) | 2008-09-03 | — | — | EP | claimed |
| US-20070065615-A1 | ANNULAR OR TUBULAR SHAPED ARTICLES OF NOVEL POLYMER BLENDS | CITIBANK, N.A., AS COLLATERAL AGENT | 2007-03-22 | — | — | US | claimed |
| CN-1871280-A | Phase transfer catalytic process for the preparation of polyetherimides | GEN ELECTRIC (US) | 2006-11-29 | — | — | CN | claimed |
| CN-1867610-A | Copolyetherimides | GEN ELECTRIC (US) | 2006-11-22 | — | — | CN | claimed |
| US-20060173158-A1 | Phase transfer catalyzed method for preparation of polyetherimides | GENERAL ELECTRIC COMPANY (US) | 2006-08-03 | — | — | US | claimed |
| EP-1660560-A2 | PHASE TRANSFER CATALYZED METHOD FOR PREPARATION OF POLYETEHRIMIDES | GENERAL ELECTRIC COMPANY (US) | 2006-05-31 | — | — | EP | claimed |
| EP-1660556-A1 | COPOLYETHERIMIDES | GENERAL ELECTRIC COMPANY (US) | 2006-05-31 | — | — | EP | claimed |
| WO-2005023901-A1 | COPOLYETHERIMIDES | GENERAL ELECTRIC COMPANY (US) | 2005-03-17 | — | — | WO | claimed |
| WO-2005021618-A2 | PHASE TRANSFER CATALYZED METHOD FOR PREPARATION OF POLYETEHRIMIDES | GENERAL ELECTRIC COMPANY (US) | 2005-03-10 | — | — | WO | claimed |
| US-20050049390-A1 | Phase transfer catalyzed method for preparation of polyetherimides | GENERAL ELECTRIC COMPANY | 2005-03-03 | — | — | US | claimed |
| US-6849706-B1 | Copolyetherimides | GENERAL ELECTRIC COMPANY (US) | 2005-02-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173158-A1 | Phase transfer catalyzed method for preparation of polyetherimides | TRRAP, RCC1, DDT | TDP1 2106/4885L3MBTL1 1690/4885MAPT 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.